Altis is accelerating clinical trials with AI endpoints. Trained on the industry's largest multimodal oncology database, Altis' AI model, IPRO, is used by leading global biopharmaceutical companies to analyze clinical trial data and detect efficacy signals earlier. Altis is on a mission to help reduce the time, cost, and failure rate plaguing therapeutic development so that patients can get access to novel, effective treatment sooner.